NEW from the Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc. for the National Cancer Institute.
Recent research adds to growing evidence that a single dose of human papillomavirus (HPV) vaccine is highly effective in protecting young women against cervical infection with cancer-causing HPV types. Read about the research, which involved Frederick National Laboratory.
https://frederick.cancer.gov/news/single-dose-hpv-vaccine-may-provide-adequate-protection